-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Theseus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2023.
- Theseus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$16.4M, a 2.85% decline year-over-year.
- Theseus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$66.5M, a 40.7% decline year-over-year.
- Theseus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$54.1M, a 97.9% decline from 2021.
- Theseus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$27.3M, a 300% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)